$CKDXF Income Statement | Understand Stock

$CKDXF

$0.01 -$0.10 (90.52%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022	FY2021 12 months to Jun 30, 2021
Revenue
Other income
Operating expenses:
Research and development (includes amounts paid to related parties $10,021, 2024:$3,043 , 2023:$900)
Patent expenses
Intellectual property expenses
Patent and intellectual property expenses
Administration expenses (includes amounts paid to related parties $275, 2024:Nil,2023: Nil)
Occupancy expenses
Interest expense on DFA
Total operating expenses
Operating Loss
Finance income
Fair value adjustment gain on DFA
Interest expense on DFA* (includes amounts to related parties $32,793 (2024: $24,699, 2023: $13,462))
Gain on remeasurement of financial liability - DFA
Fair value gain/(loss) on derivatives - investor options
Net foreign exchange loss

Loss before income tax
Income tax benefit
Loss for the year
Total comprehensive loss for the year is attributable to:
Owners of the Company
Other comprehensive income
Fair value gains on investments in financial assets
Other comprehensive income for the period, net of tax
Total comprehensive loss for the year

Loss per share attributable to the owners of the Company:
- Basic and diluted loss per share (cents)
- Basic loss per share (cents)
- Diluted loss per share (cents)

Loss for the year is attributable to:
Owners of the Company

Comments